Next-gen medical devices combine traditional medical equipment with advanced software and technologies like AI, machine learning (ML), robotics, and sophisticated sensors. These devices are becoming smarter and smaller, offering new features that support patient diagnosis, treatment, and monitoring. They aim to provide better security, safety, and integration with clinical workflows and improved data management and patient experience.
These devices can be categorized into diagnostic, treatment, and monitoring tools. Diagnostic devices use AI and other technologies for precise and early disease detection; treatment devices employ AI and robotics for personalized care and less invasive procedures; and monitoring devices use smart sensors and the Internet of Medical Things (IoMT) to track vital signs continuously.
The demand for these advanced medical devices is growing due to several factors. The increase in chronic diseases, especially among older populations, creates a need for innovative solutions. The shortage of healthcare workers drives the adoption of technologies that can enhance efficiencies. Additionally, the high cost of healthcare, particularly in the US, is encouraging the use of devices that can optimize resources and cost-effectively improve patient outcomes. However, challenges such as FDA approval processes and integration with legacy healthcare systems must be addressed.
Next-gen medical devices are being deployed primarily in the healthcare sector to enable use cases like robotic-assisted surgeries, patient monitoring, diagnosis, and treatment. Software that enhances medical devices—often known as software-as-a-medical-device—has seen recurring use cases in automating laboratory workflows.
In addition to healthcare, next-gen medical devices are being used in other industries, such as education, or in elements of the public sector, like correctional facilities to enable training and monitoring.
We have identified key Next-gen Medical devices use cases below:
The next-gen medical devices space consists of players that combine traditional medical equipment with advanced software and technologies like AI, machine learning (ML), robotics, and sophisticated sensors to develop various diagnostic, treatment, and monitoring tools. Most companies are concentrated in the surgical devices segments, along with significant focus on non-implantable surgical devices. Providers of developer tools make up the smallest segment in this space.
As of September 2024, the surgical devices segment had raised USD 7 billion—over half of the industry’s funding. The diagnostic devices segment followed, with over USD 2 billion raised as of the same date.
Big Techs such as Johnson & Johnson, GE Healthcare, and Siemens Healthineers are among the active incumbents in this space, focusing on one or a few segments.
Disruptors in the next-gen medical devices space are predominantly at an go-to-market or minimum viable product stage, with around 80% established after 2010. Most players focus on developing a specific product or product range for a specific market segment.
CMR Surgical is the highest-funded disruptor, with total funding of over USD 1 billion as of September 2024, followed distantly by Asensus Surgical, with funding of ~USD 475 million. While there are relatively few listed players in the industry, some notable ones include Sonendo, Sientra, and Vicarious Surgical.
Global companies such as Johnson & Johnson, GE Healthcare, and Siemens Healthineers are active incumbents in the Next-gen Medical Devices space. Generally, most incumbents focus on one particular industry segment rather than diversifying across various segments. Within their respective domains, many of these incumbents offer a wide range of solutions, often driven by the need to incorporate the latest technologies to keep pace with the market. Johnson & Johnson, GE Healthcare, and Insightec are some companies operating in more than one segment.
Incumbents' offerings predominantly include products designed and built in-house or through various product partnerships. However, incumbents also leverage acquisitions to fuel growth and diversification. One of the most notable acquisitions is Medtronic acquiring Covidien for USD 42.9 billion in June 2014, and more recent examples include Stryker’s acquisition of Wright Medical Group for USD 4 billion in November 2019 and GE Healthcare's acquisition of BK Medical for USD 1.5 billion in September 2021.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.